-
News | 2018.12.10
Demystifying immunity in the bladder
A European Union-funded project set out to study the bladder's immune system, with the aim of advancing our understanding of UTI and bladder cancer to improve treatment of these diseases. Dr. Molly Ingersoll, researcher at the Institut Pasteur, is leading the project.We know that the bladder is a poorly understood organ, critical for storing metabolic waste. What we don’t know is how this unique...
-
News | 2018.12.11
Distinguishing resistence from resilience to prolong antibiotic potency
Biomedical engineers at Duke University, in collaboration with Inria and the Institut Pasteur (Paris), have shown experimentally that there is more than one flavor of antibiotic resistance and that it could - and should - be taken advantage of to keep first-line antibiotics in our medical arsenal.In a study appearing online Dec. 7 in the journal Science Advances, the researchers show why doctors...
-
News | 2018.12.17
WHO high-level meeting on preparedness in public health emergencies
On December 4th, The Institut Pasteur International Network (IPIN) participated in a high-level meeting on preparedness in public health emergencies and the challenges and opportunities in urban areas organized by World Health Organization (WHO) in Lyon.The objective of this conference was to identify gaps and challenges, to foster intersectoral and multidisciplinary collaboration (including a "...
-
News | 2018.12.17
A biological interface for prostheses: the futuristic project of the 2018 Pasteur iGEM team
On December 11, 2018, the Institut Pasteur awarded the 20 students of the 2018 Pasteur iGEM team. They came back with a gold medal from the competition that was held in Boston from October 24 to 28. Each year, the Massachusetts Institute of Technology (USA) organizes the international competition iGEM (Genetically Modified International Machine), which promotes research in synthetic biology. For...
-
News | 2018.12.17
Tumor cells eliminating their neighbors using a newly discovered mechanism
How do tumoral cells replace healthy cells to promote tumor progression? Scientists from the Institut Pasteur (Paris, France) and from the Champalimaud Centre for the Unknown (Lisbon, Portugal) identified a mechanism that responds to cell deformation and can be exploited by tumoral cells to squeeze out and kill their neighbors. This mechanism may promote the early expansion of tumors.Despite...
-
News | 2019.01.02
Food contamination in Cambodia contributing to the burden of antibiotic resistance
As antibiotics efficacy is under real threat, the World Health Organization warns that "one day no antibiotics may be left to treat common bacterial infections". Infections caused by bacteria that are resistant to antibiotics are more difficult and expensive to treat, with a higher risk of treatment failure. Antibiotic resistance is particularly problematic in lower and middle-income countries (...
-
News | 2018.12.18
Five young researchers from the Institut Pasteur International Network, at the 2018 doctoral ceremony
On 7 December 2018, the Institut Pasteur organized a ceremony in honor of young graduates who completed their science thesis at the Institut Pasteur during the 2017-2018 academic year. This ceremony exists since 2013. Opened by an exceptional conference of Prof. Serge Haroche, Nobel Prize in Physics 2012, the 2018 edition honored, among these young Pasteurian scientists, five who completed their...
-
Document de presse | 2018.12.20
AIDS – an approach for targeting HIV reservoirs
Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus – it is their metabolic (or energy-producing) activity1 that enables the virus to multiply. Thanks to...
-
News | 2018.12.18
The medical entomology course at the Institut Pasteur celebrates its 30th anniversary
Entomology, the study of insects, is a long-standing tradition at the Institut Pasteur. Institut Pasteur scientist Alphonse Laveran was the first to describe the malaria agent, Plasmodium, in 1880, while working in Constantine, Algeria. His work on protozoa earned him the Nobel Prize in 1907. In 1898, Paul-Louis Simond demonstrated that the bacterium responsible for plague, the Yersinia pestis...
-
Document de presse | 2018.12.21
A novel antibiotic resistance mechanism
Bacteria make use of a number of natural resistance strategies to overcome antibiotics. And it seems that this bacterial toolbox may be much more varied than previously thought. Scientists at the Institut Pasteur, in collaboration with Inserm, INRA, the CNRS and the Weizmann Institute of Science in Israel, have recently revealed an entirely unknown resistance mechanism in Listeria monocytogenes...
